Expres2ion Biotech Holding AB
Acquisition
Finansinspektionen (SE) · published 2026-10-09T14:11:23+00:00
Summary
Today, on 2026-10-09, Bent Frandsen acquired 10,000 ExpreS2ion Biotech Holding AB at 1.10 SEK per unit, total 11,000 SEK. The latest reported price for this instrument is 1.15 SEK per unit (2026-10-02). On paper the insider is up 500 SEK on this transaction.
No market quote was available, so the reference price is the most recent price reported in MAR filings for this instrument.
- Insider
- Bent Frandsen
- Position
- Chief Executive Officer (CEO)/Managing Directory
- Closely associated
- No
- Notifier
- Bent Frandsen
- Instrument
- ExpreS2ion Biotech Holding AB
- Instrument type
- Share
- ISIN
- SE0023261292
- Transaction date
- 2026-10-09
- Volume
- 10,000 Quantity
- Price
- 1.10 SEK
- Transaction total
- 11,000 SEK
- Venue
- FIRST NORTH SWEDEN
- Status
- Current